David T. Rubin, MD, FACG
David T. Rubin, MD, FACG

Simultaneous Symposia 1a: Choosing and Monitoring Biologic Therapy for IBD
Monday, October 20
11:30 am – 12:45 pm
Moderator: David T. Rubin, MD, FACG

Positioning Biologics in Ulcerative Colitis
Bruce E. Sands, MD, FACG
Describe how timing and selection factor into the implementation of biologic therapy for UC.

Positioning Biologics in Crohn’s Disease
David T. Rubin, MD, FACG
Describe how timing and selection factor into the implementation of biologic therapy for Crohn’s disease.

Appropriate Use and Interpretation of Drug Levels
Marla C. Dubinsky, MD
Incorporate a rational approach to therapeutic drug monitoring in IBD.